巨騰國際(03336.HK)向山善株式會社採購1.63億港元設備
格隆匯8月18日丨巨騰國際(03336.HK)公告,於2020年5月19日、5月25日、6月19日、7月15日、8月5日及8月18日,集團與山善株式會社分別訂立2020年設備協議I、設備協議II、設備協議III、設備協議IV、設備協議V及設備協議VI,據此,山善株式會社同意出售及集團同意採購該設備,總代價約為1.63億港元。
集團的策略為擴大有更高利潤率的產品之生產,其中包括金屬機殼。集團需要設備以供集團位於中國的生產廠房生產金屬機殼之用,這與集團的策略及業務需要一致。因此,董事會認為,與山善株式會社訂立該等2020年設備協議對集團有利,因其可促進此類設備的採購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.